Approved Hospital Formulary
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

eptifibatide

eptifibatide
Brand names: Integrilin
Form Strength
SOLUTION, INTRAVENOUS 0.75 mg/mL; 2 mg/mL


Additional Information:

As of June 2016, eptifibatide is a non-formulary medication.  The formulary Glycoprotein 2b/3a Inhibitor agent of choice is tirofibanEptifibatide may be available for patients already started on medication outside of Legacy Health.


Neuraxial Anesthesia and Anticoagulation: see Guideline 900.5681

Cardiac/Telemetry Units: Guidelines for cardiac and vasoactive IV drugs: See Policy 900.5386


Last updated: Jun. 7, 2017







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.